Search

everythinglearnresearchcommunity

for

Search:↓

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

CD2 might be a new treatment target for patchy alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Probiotic bacteria improved skin and hair health in aged mice.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

More research is needed to understand and manage rheumatoid arthritis better.